Mark Poeschl
Chief Executive Officer
Furst-McNess Company
1252 Bell Valley Road, Suite 220
Rockford , IL 61108
United StatesFEI 3002787852Issued Mar 12, 2024Division of Human and Animal Food Operations West I
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3002787852.
Violations8
Issue DateMar 12, 2024
Product TypeDrugs
StatusOpen
Letter Details
Firm
Furst-McNess Company
Location
Mark Poeschl
Chief Executive Officer
Furst-McNess Company
1252 Bell Valley Road, Suite 220
Rockford , IL 61108
United States
FEI Number
3002787852
Country
United States
Issue Date
March 12, 2024
Issuing Office
Division of Human and Animal Food Operations West I
Product Type
Drugs
Status
Open
Summary
Furst-McNess Company's medicated goat feed manufacturing facility was cited for producing an adulterated animal feed product (B9251, 18% Goat Starter) that contained excessive monensin concentrations, resulting in multiple goat illnesses and deaths that prompted a voluntary Class I recall in August 2023. The inspection revealed significant violations of Current Good Manufacturing Practice (CGMP) for Medicated Feeds under 21 CFR Part 225 and failures to implement required Hazard Analysis and Risk-Based Preventive Controls for Food for Animals under 21 CFR Part 507. The monensin-containing feed was deemed unsafe because the new animal drug was not used in conformance with its approved application, making the product adulterated under federal regulations.
Furst-McNess Company FDA Warning Letter, March 12, 2024